Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 27, 2015
Issued Date -
N/A
app pub date -
Sep 9, 2011
filing date -
Sep 13, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present disclosure relates to purine compounds of formula (I) or formula (II) or its tautomers, polymorphs, stereoisomers, solvates or a pharmaceutically acceptable salts, or pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by thereof as A2B adenosine receptor antagonists.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully